TrialBritish journal of haematology2025

Distinct patient, tumour and chimeric antigen receptor T-cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma.

Nathan Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.